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OBJECTIVEdRecently, sleep-disordered breathing (SDB) has been reported to be associated
with the development of gestational diabetes mellitus (GDM). Accordingly, as this is emergent
area of research that has signiﬁcant clinical relevance, the objective of this meta-analysis is to
examine the relationship between SDB with GDM.
RESEARCH DESIGN AND METHODSdWe searched several electronic databases for
all of the studies published before January 2013 and reviewed references of published articles.
Meta-analytic procedures were used to estimate the unadjusted and BMI-adjusted odds ratios
(ORs) using a random effects model. Signiﬁcant values, weighted effect sizes, and 95% CIs were
calculated, and tests of homogeneity of variance were performed.
RESULTSdResults from nine independent studies with a total of 9,795 pregnant women
showed that SDB was signiﬁcantly associated with an increased risk of GDM. Women with
SDB had a more than threefold increased risk of GDM, with a pooled BMI-adjusted OR 3.06
(95% CI 1.89–4.96).
CONCLUSIONSdThese ﬁndings demonstrate a signiﬁcant association between SDB and
GDM that is evident even after considered confounding by obesity. This meta-analysis indicates a
need to evaluate the role of early recognition and treatment of SDB early during pregnancy.
Diabetes Care 36:3353–3360, 2013
Gestational diabetes mellitus (GDM)is deﬁned as carbohydrate intoler-ance of variable severity with onset
or ﬁrst recognition during pregnancy and
often diagnosed at 24–28 weeks of gesta-
tion (1–3). GDM is a major concern for
public health, as the number of affected
women is expected to rise as a result of
increased sedentary habits and hyper-
caloric diets (4).
The impact of GDM on maternal and
fetal health is well established. The Hyper-
glycemia and Adverse Pregnancy Outcome
(HAPO) study showed that globally, GDM
is associated with adverse perinatal and
maternal outcomes such as fetal macro-
somia, preeclampsia, primary cesarean sec-
tion, neonatal hypoglycemia, premature
delivery, intensive neonatal care, and hy-
perbilirubinemia, as well as with increased
levels of cord blood serum C-peptide (5–8).
The HAPO study also demonstrated that as-
sociations between maternal glycemia and
adverse outcomes are continuous across
the range of glucose concentrations and
are observable even below diagnostic levels
of diabetes (9). This broad range of mor-
bidity indicates a need to identify modiﬁ-
able risk factors for impaired glucose
tolerance in pregnancy.
Sleep-disordered breathing (SDB) has
emerged as an important risk factor for
the development of high blood pressure,
heart failure, stroke, diabetes, atrial ﬁbril-
lation, and premature mortality (10–12).
The risk is particularly elevated among
racial/ethnic minority groups and individ-
uals from disadvantaged neighborhoods.
Mounting evidence, from observational
and experimental intervention studies, in-
dicates that sleep disturbances, such as SDB
(deﬁned as habitual snoring or sleep study–
documented obstructive sleep apnea), are
associated with poor glucose control and
possibly GDM (13,14).
Experimental studies have shown
that short sleep duration decreases insulin
sensitivity compared with longer sleep
(15,16). Experimental overnight inter-
mittent hypoxemia, an essential feature
of SDB, also alters glucose metabolism
in animal and human studies (17,18). Ep-
idemiological studies have shown that
SDB is a risk factor for prevalent and in-
cident diabetes, and recent clinical trials
indicate that metabolic abnormalities im-
prove with treatment of SDB (19,20).
Recently, SDB has been reported to be
associated with the development of GDM
(21). This ﬁnding, if conﬁrmed across
populations, has a potential large public
health impact related to the increasing
prevalence of obesity, a major risk factor
for SDB. The objective of this meta-analysis
is to examine whether SDB is associated
with the occurrence of GDM and to assess
the extent to which such an association is
inﬂuenced by control for prepregnancy or
early pregnancy BMI.
RESEARCH DESIGN AND
METHODSdThis meta-analysis was
conducted according to internationally
accepted reporting guidelines (22).
Data sources and study selection
Studies were identiﬁed by searching the
National Center for Biotechnology’s
PubMed/MEDLINE database, Embase
(Elsevier), the Web of Science (Thomson),
BIOSIS (Thomson), CINAHL (EBSCO),
Cochrane Central (Wiley), and the reviews
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and registry of the Cochrane Pregnancy
and Childbirth group. Controlled vocabu-
lary terms (e.g., MeSH or Emtree terms)
were used when available and appropriate.
No language or date limits were applied.
Additionally, we reviewed the bibliogra-
phies of relevant articles and consulted
with experts in the ﬁeld to identify studies
not otherwise indexed or discoverable. The
termsused to interrogate each databases are
presented in the Supplementary Table 1.
Criteria for study inclusion into the
review
First, the titles were reviewed to exclude
any studies not related to the objective of
this meta-analysis. A priori articles were
considered for full reading if authors re-
ported data from an original peer-reviewed
study (i.e., not case reports, comments,
letters, meeting abstracts, or review arti-
cles), and study designs were prospective
or retrospective cohort or case-control
study.
Full texts of the selected studies were
then retrieved and read in full in an
unblinded and independent manner by
two authors (M.A.L.-F. and B.G.). Studies
were considered eligible for full manu-
script data extraction if the study met all
the following criteria: 1) study partici-
pants were pregnant women without a di-
agnosis of diabetes requiring treatment
prior to pregnancy, 2) the study consid-
ered SDB as an exposure and deﬁned and
evaluated SDB as habitual snoring or an
apnea hypopnea index $5 using over-
night sleep monitoring (23,24), 3) the
study considered GDM as an outcome
and diagnosed participants with fasting
glucose or the oral glucose tolerance test
(OGTT) following international validated
medical criteria (3,25,26), and 4) the study
included an assessment of obesity, mea-
sured during the prepregnancy period or
during early pregnancy. Disagreement
was resolved by a third author (M.A.W.)
who independently examined the studies.
Data extraction
We developed a modiﬁed data extraction
sheet based on the Cochrane Consumers
andCommunication ReviewGroup’s data
extraction template and pilot tested it on
two randomly selected included studies
(27). Two authors (M.A.L.-F. and B.G.)
extracted the data from the included stud-
ies, and the other authors reviewed the
extracted data.
We extracted and recorded speciﬁc data
from studies: authors, year of publica-
tion, country of origin, study design, total
sample size, measure used to assess SDB,
the recall period between the assessment of
the exposure and the diagnosis of GDM,
diagnosis criteria to evaluate GDM, whether
the study restricted the sample to single-
ton pregnancies, adjustment or stratiﬁca-
tion by BMI in multivariate analysis, and
type of BMI measurement (prepregnancy
or during early pregnancy).
Quality assessment
We assessed the methodological quality
and risk of bias for each study based on
the Newcastle-Ottawa quality criteria for
observational studies (28) (Supplemen-
tary Table 2). In addition, a study was
considered to be of high quality based
on 1) the observational design being
considered a case-control, prospective,
or retrospective cohort; 2) case and con-
trol subjects being well deﬁned; 3) the re-
call period speciﬁed; 4) the exposure
being measured using standardized SDB
screening questionnaires (24) or by an
objective measurement (29); and 5) in
multivariate analysis the measure of asso-
ciation being adjusted or stratiﬁed by BMI
in multivariate analysis, as SDB and GDM
both are associated with increased adi-
posity (30,31). One author was contacted
to clarify whether the association between
SDB and GDM was adjusted by BMI in
multivariate analysis.
After the quality assessment and prior
to conducting the pooled analysis, we
assumed that effect size of the association
between SDB and GDM may differ ac-
cording to the methodological quality of
the studies. Therefore, we decided a priori
to use a random effects meta-analysis
approach. In addition, we assessed the
overall risk of bias by conducting sensi-
tivity analyses to explore possible sources
of heterogeneity across studies.
Data synthesis and statistical
analysis
First, we described the characteristics of
each included study summarizing the
information of the extracted data and
the quality assessment (Table 1 and Sup-
plementary Table 2). Afterward, we used
the Stata (Stata, College Station, TX) pro-
gram “metan” (32) to generate summary
and pooled odds ratios (ORs) using an
inverse variance-weighted random effects
analysis based on the DerSimonian and
Laird method to account for within- and
between-study variation (33).
Summary and pooled ORs were rep-
resented as a point estimate and 95% CIs
on a forest plot (34). The assumption of
homogeneity of true effect sizes was as-
sessed by the Cochran Q test, and the de-
gree of heterogeneity across studies was
calculated presenting the I2 statistic and
95% CI (35,36).
In order to explain the source of
heterogeneity, we conducted a subgroup
analysis based on whether the effect of
BMI during the study design or analysis
was conceptualized as a confounder or as
an effect modiﬁer. When assessing any
source of variability between studies that
could explain the presence of heteroge-
neity, subgroup analysis is considered the
best approach, as it is easily done and is
preferred when the number of studies is
short rather than a meta-regression (35).
We evaluated publication bias using a
Funnel plot (37).
Finally, as planned a priori, we con-
ducted sensitivity analyses based on the
knowledge of individual studies rather
than applying weights to studies in the
meta-analysis based simply on quality
scoring criteria (38).We assessed whether
the type of SDB measurement (question-
naire or polysomnography), the type of
study (case-control or cohort), and BMI
used as a confounder or effect modiﬁer in
multivariate analysis explained the vari-
ability across studies.
RESULTSdThe systematic search
yielded 873 total references, of which
579 were unique.With use of prespeciﬁed
inclusion criteria, a title review rejected
514 references, yielding 65 candidate
abstracts. A subsequent abstract review
rejected 56 of these references, yielding
nine candidate studies. Each of these
studies was reviewed and selected for
data extraction; however, based on quality
criteria we decided to differentiate two
groups for further subgroup analysis. One
group was constituted of six studies (39–
44) that included BMI in multivariate
analysis, whereas the other was consti-
tuted of three studies that only presented
unadjusted measures of association with-
out adjustment by BMI (45–47). Among
the BMI-adjusted studies, four used BMI
in multivariate analysis as a classic con-
founder (39–42), while two stratiﬁed the
analysis by BMI (Fig. 1) (43,44).
A total of 9,795 pregnant women
were included in the analysis. Study pop-
ulations included were primarily located in
the U.S. (seven studies), whereas the other
two study populations were from Turkey
and Taiwan (42,47). All included studies
were observational; seven were designed
as prospective or retrospective cohorts,
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while two were hospital- or population-
based case-control studies (42,46). Four
studies restricted the sample to singleton
pregnancies (40,42,44,46).
Only three studies used an objective
measurement of SDB (obstructive sleep
apnea deﬁned as an elevated apnea hypopnea
index on polysomnography), while the
others identiﬁed habitual snoring dur-
ing pregnancy using standardized ques-
tions (24). Four studies did not specify
the criteria used to diagnose GDM
(42,44,46,47), and three studies did not
present an adjustedmeasure of association
(45–47) (Table 1).
Overall, SDB (determined by habitual
snoring or polysomnography-documented
obstructive sleep apnea) during the index
pregnancy were statistically signiﬁcantly
associated with the diagnosis of GDM.
The unadjusted OR for the risk of develop-
ing GDM in women with SDB for each of
the nine individual studies included in the
meta-analysis ranged from 1.44 (95% CI
1.00–2.10) to 7.63 (95% CI 1.21–48.25),
with a summary pooled unadjusted OR of
2.18 (95% CI 1.59–2.99). Approximately
53% of the variability between studies’
measures of associationwas due to the pres-
ence of a moderate heterogeneity, assessed
through the statistic I2 (53% [95% CI 0–
78]), Cochran Q test P value = 0.031
(Fig. 2).
The pooled BMI-adjusted OR of the
six studies analyzing the effect of SDB
on GDB (37–42) was 3.06 (95% CI
1.89–4.96), and the studies’ speciﬁc
measures of association ranged from
1.63 (95% CI 1.07–2.48) to 6.90 (95%
CI 1.40–33.95). Approximately 62%
of the variability between studies was
due to moderate heterogeneity, with an
I2 61% (95% CI 5–84), Cochran Q test
P value = 0.024 (Supplementary Fig. 1).
We found BMI as an important factor that
explains heterogeneity across studies.
Hence, we presented our ﬁnal results
based on a stratiﬁed analysis, consisting
of four studies using BMI as a confounder
in multivariate analysis (39–42) and two
other studies that considered BMI as an
effect modiﬁer (as inferred by the presen-
tation of BMI-stratiﬁed results) (43,44)
(Fig. 3).
Figure 3 shows that the summary
pooled adjusted OR of the subgroup of
studies that adjusted for BMI was 2.17
(95% CI 1.45–3.25), with individual
study–adjusted ORs ranging from 1.63
(95% CI 1.07–2.48) to 6.90 (95% CI
1.40–33.95). The BMI-adjusted sub-
group showed low evidence of heteroge-
neity among studies, with an I2 33% (95%
CI 0–76), Cochran Q test P value = 0.217.
The summary pooled OR of the second
subgroup of studies that stratify results
by BMI was 5.27 (95% CI 2.87–9.66),
and the speciﬁc studies’measures of asso-
ciation ranged from 4.12 (95% CI 1.78–
9.53) to 6.90 (95% CI 2.87–16.59). This
subgroup showed no evidence of hetero-
geneity, with a P value = 0.405 (Cochran
Q test).
Sensitivity analyses based on the
stratiﬁcation of SDB deﬁned as habitual
snoring (subjective measurement) or
documented obstructive sleep apnea (ob-
jective measurement) shows that the
pooled OR of the studies that used habit-
ual snoring as the exposure measure was
2.46 (95% CI 1.63–3.71), while the OR
was 1.79 (95% CI 0.91–3.53) for the
studies that modeled objectively mea-
sured SDB. Furthermore, stratiﬁed analy-
sis by type of study (case-control or
cohort) also shows no evidence of varia-
tion, with a pooled OR 2.34 (95% CI
1.61–3.41) for the cohort studies and
2.20 (95% CI 1.99–2.94) for the case-
control studies.
Finally, there was no evidence of a
signiﬁcant publication bias (Supplemen-
tary Fig. 2), conﬁrmed by the Egger test
for publication bias (H0: intercept = 0;
P value = 0.724).
CONCLUSIONSdTo our knowledge,
this is the ﬁrst meta-analysis examining
Figure 1dFlowchart of the systematic literature review.
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the evidence for an association between
SDB and GDM. Overall, in a pooled anal-
ysis we observed a signiﬁcant association
between SDB (deﬁned as habitual snor-
ing or an increase in the measured ap-
nea hypopnea index) and risk of GDM.
Women with SDB during pregnancy had
more than a threefold increased risk of
GDM. Furthermore, a signiﬁcant associa-
tion was demonstrated in analyses that
considered confounding or effect modiﬁ-
cation by BMI.
Strengths and limitations
The primary strengths of this meta-
analysis include the expansive literature
search and inclusion of ~10,000 pregnant
women, pooled from nine peer-reviewed
published articles. Our ﬁndings, consis-
tent with prior hypotheses in the litera-
ture, suggest SDB as a novel risk factor for
GDM. In addition, we examined the inﬂu-
ence of BMI (prepregnancy or early preg-
nancy BMI) on the association between SDB
and GDM. We also explored potential het-
erogeneity associated with use of alternative
metrics to assess SDB (habitual snoring or
measured obstructive sleep apnea).
Results from this meta-analysis must
be interpreted in light of the following
limitations. First, the nature of the evi-
dence of this meta-analysis is based on
observational studies. Meta-analyses are
not designed to address problems with
residual confounding that may be inherent
in the original studies and does not address
causality. Following international guide-
lines, we have used the Meta-analysis of
Observational Studies in Epidemiology
(MOOSE) statement and the Newcastle-
Ottawa criteria to assess the quality of the
selected studies.
Therefore, based on quality criteria
for observational studies, we have some
conﬁdence that the selected studies are
not biased and our pooled measure of
association has sufﬁcient power to avoid a
systematic statistical type II error. In
addition, we have presented stratiﬁed
analyses by BMI, type of SDBmeasurement
(polysomnography or questionnaire), and
type of study (case-control or cohort) in
order to explore sources of variability
across studies.
Second, while the majority of studies
to date have been conducted in U.S., two
studies were conducted in Taiwan and
Turkey, respectively. Thus, given the
growing problem of SDB and GDM glob-
ally, more variability in terms of geograph-
ical representation of the populations of
pregnant women is needed.
Third, although we found no statisti-
cally signiﬁcant evidence for publication
bias, we cannot exclude the possibility
that publication bias may have affected
the results.
Finally, given that some studies used
habitual snoring rather than objective
recordings of obstructive sleep apnea, it
is possible that there may be some mis-
classiﬁcation in SDB status, although
sensitivity analysis stratiﬁed by the objec-
tive and subjective measurement of SDB
did not show signiﬁcant differences. Snor-
ing, an indicator of airﬂow limitation, is in
general a fairly sensitive but not speciﬁc
symptom of obstructive sleep apnea, which
characteristically causes overnight inter-
mittent hypoxemia. Self-reported snoring
also does not provide quantitative data on
the severity of overnight hypoxemia, which
may be a critical driver of metabolic dis-
turbances (48).Thus, if the relevant expo-
sure increasing risk of GDM is related to
intermittent hypoxemia rather than due
to less severe airﬂow limitation, there may
have been an underestimation of the asso-
ciations. Future research using quantita-
tive metrics of overnight hypoxemia may
elucidate whether there are “exposure-
response” associations or thresholds of
SDB severity that are associated with in-
creased risk of GDM. Nonetheless, snoring
history is a readily accessible measure that
can be identiﬁed in routine clinical obstet-
rical care and thus is directly relevant for
clinicians as an initial step in assessing risk.
Interpretation
The results from subgroup analysis com-
paring effect estimates for analyses that
adjusted for BMI compared with those
two that stratiﬁed by obesity suggest that
the association between SDB and GDM
Figure 2dForest plots showing studies’ unadjusted ORs of the association between SDB and GDM and the pooled summary OR (n = 9).
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may be stronger in obese women. How-
ever, these results have to be interpreted
cautiously owing to the relatively small
number of studies and their observational
design that precludes delineation of the
temporal relation between SDB and GDM.
These associations may result from bidi-
rectional relationships or they may be the
outcome of a third factor affecting both
glucose metabolism and breathing during
sleep, such as weight gain during preg-
nancy or psychosocial stressdboth areas
that warrant further investigation using ob-
servational causal inference methodologi-
cal tools (49). Nonetheless, we consider
the fact that all crude estimates of the ana-
lyzed studies showed higher odds of GDM
for women with SDB to be a consistent
ﬁnding that strengthens the evidence of
the observed association.
There are several possible pathophys-
iological mechanisms that may explain
the observed relationship of SDB and
GDM. SDB causes recurrent arousals
from sleep (50); sleep fragmentation
with a resultant decrease in slow-wave
sleep (stage N3) has been shown to alter
the effectiveness of both glucose tolerance
and insulin sensitivity (21). Reduced
stage N3 has been linked to increased
risk of impaired glucose tolerance and
insulin sensitivity (51), presumably as a re-
sult of the disruption of the hypothalamic-
pituitary-adrenal axis or through increased
activity of the sympathetic nervous sys-
tem. Alterations in cortisol synthesis and
release may also represent a mechanism
through which altered sleep disrupts
glucose metabolism (21). And ﬁnally, in-
termittent hypoxemia occurring in as-
sociation with recurrent apneas and
hypopneas facilitates the generation of
reactive oxidative species resulting in in-
creased oxidative stress and proinﬂamma-
tory cascade, dyslipidemia, and insulin
resistance (21). Intermittent hypoxemia
also may negatively inﬂuence pancreatic
b-cell function (52). Since the majority of
normal pregnancies are accompanied with
some degree of insulin resistance and a re-
duction in the duration or quality of sleep,
which independently of SDB may impair
glucose metabolism (13), pregnancy may
be a time of particular vulnerability to
SDB-related stresses and adverse metabolic
outcomes.
Implications
The prevalence of GDM in the U.S. con-
tinues to be a major concern for public
health, as the number of affected women
is expected to rise as a result of the high
prevalence of obesity in women as they
enter pregnancy. Results of this study sug-
gest that even after considering the effects of
prepregnancy obesity, SDB is a factor risk of
GDM. In addition, the association between
SDB and GDMmay be stronger in obese or
overweight women. The recognition and
treatment of SDB early during pregnancy
may lead to improved outcomes.
Currently, there are no speciﬁc guide-
lines for screening pregnant women for
SDB. The results of this meta-analysis
indicate the potential importance of con-
sidering screening for SDB in high-risk
pregnancies, especially among obese
women or women who gain excessive
weight during pregnancy. The usefulness
of current pregnancy guidelines for re-
ducing SDB in pregnancydsuch as sleep-
ing in a lateral sleeping position or with
head elevation, treatment of nasal conges-
tion, and avoidance of sedatives, alcohol,
excessive gestational weight gain, and
sleep deprivationdas well as the utility
of formal sleep apnea testing and treat-
ment, needs evaluation (48).
Some studies of the general popula-
tion with SDB that have shown clear
Figure 3dSubgroup analysis: Forest plots showing studies’ adjusted ORs of the association between SDB andGDMand the pooled summaryOR (n = 6).
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improvement in insulin resistance and
glycemic control after nasal continuous
positive airway pressure (CPAP) treat-
ment, while others have not (53). Nasal
CPAP therapy has been used and tolerated
during pregnancy (54), and no adverse
events were reported among pregnant
women with obstructive sleep apnea who
were treated with nasal CPAP (55,56). Our
analysis also indicates the need for research
to evaluate the role of CPAP in modifying
risk of GDM (53).
In summary, this systematic review
and meta-analysis contributes to the
growing evidence of the increased risk
of GDM in women with preexisting or
pregnancy-associated SDB.
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